| 000 | 01855 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513153424.0 | ||
| 264 | 0 | _c19981026 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1998.16.10.3302 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLilenbaum, R C | |
| 245 | 0 | 0 |
_aPhase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cOct 1998 |
||
| 300 |
_a3302-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 700 | 1 | _aMiller, A A | |
| 700 | 1 | _aBatist, G | |
| 700 | 1 | _aBernard, S | |
| 700 | 1 | _aHollis, D R | |
| 700 | 1 | _aRosner, G L | |
| 700 | 1 | _aEgorin, M J | |
| 700 | 1 | _aSchilsky, R L | |
| 700 | 1 | _aRatain, M J | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 16 _gno. 10 _gp. 3302-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1998.16.10.3302 _zAvailable from publisher's website |
| 999 |
_c9744339 _d9744339 |
||